Media & Entertainment
Build Your Comparison
Side-by-side financial analysisStock Comparison
CTCT vs MCHP vs CRM vs JPM vs KO
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Software - Application
Banks - Diversified
Beverages - Non-Alcoholic
CTCT vs MCHP vs CRM vs JPM vs KO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Media & Entertainment | Semiconductors | Software - Application | Banks - Diversified | Beverages - Non-Alcoholic |
| Market Cap | $1.02B | $51.54B | $135.86B | $896.00B | $355.61B |
| Revenue (TTM) | $362M | $4.37B | $42.83B | $280.33B | $49.28B |
| Net Income (TTM) | $20M | $-97M | $8.02B | $57.05B | $13.70B |
| Gross Margin | 73.1% | 55.4% | 77.6% | 60.0% | 61.7% |
| Operating Margin | 7.6% | 4.1% | 21.9% | 25.9% | 29.3% |
| Forward P/E | 72.8x | 60.7x | 14.1x | 14.4x | 25.3x |
| Total Debt | $12M | $5.67B | $17.18B | $942.38B | $45.49B |
| Cash & Equiv. | $104M | $772M | $7.33B | $343.34B | $10.27B |
CTCT vs MCHP vs CRM vs JPM vs KO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Microchip Technolog… (MCHP) | 100 | 180.9 | +80.9% |
| Salesforce, Inc. (CRM) | 100 | 88.6 | -11.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTCT vs MCHP vs CRM vs JPM vs KO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTCT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 16.2%, EPS growth 91.3%, 3Y rev CAGR 15.7%
- 16.2% revenue growth vs MCHP's -42.3%
MCHP ranks third and is worth considering specifically for defensive.
- Beta 1.70, yield 1.9%, current ratio 2.59x
- +42.9% vs CRM's -37.1%
CRM is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.64, Low D/E 29.0%, current ratio 0.76x
- Beta 0.64 vs MCHP's 1.70, lower leverage
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs MCHP's 310.9%
- PEG 0.81 vs KO's 2.26
- Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
KO carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 56 yrs, beta -0.20, yield 2.5%
- 27.8% margin vs MCHP's -2.2%
- 2.5% yield, 56-year raise streak, vs MCHP's 1.9%, (1 stock pays no dividend)
- 13.1% ROA vs MCHP's -0.7%, ROIC 15.8% vs 1.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs MCHP's -42.3% | |
| Value | Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26 | |
| Quality / Margins | 27.8% margin vs MCHP's -2.2% | |
| Stability / Safety | Beta 0.64 vs MCHP's 1.70, lower leverage | |
| Dividends | 2.5% yield, 56-year raise streak, vs MCHP's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.9% vs CRM's -37.1% | |
| Efficiency (ROA) | 13.1% ROA vs MCHP's -0.7%, ROIC 15.8% vs 1.8% |
CTCT vs MCHP vs CRM vs JPM vs KO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CTCT vs MCHP vs CRM vs JPM vs KO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
KO leads 2 • CTCT leads 0 • MCHP leads 0 • CRM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MCHP and KO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 774.7x CTCT's $362M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to MCHP's -2.2%. On growth, MCHP holds the edge at +15.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $362M | $4.4B | $42.8B | $280.3B | $49.3B |
| EBITDAEarnings before interest/tax | $52M | $881M | $12.2B | $81.4B | $15.5B |
| Net IncomeAfter-tax profit | $20M | -$97M | $8.0B | $57.0B | $13.7B |
| Free Cash FlowCash after capex | $38M | $820M | $14.7B | $100.9B | $12.6B |
| Gross MarginGross profit ÷ Revenue | +73.1% | +55.4% | +77.6% | +60.0% | +61.7% |
| Operating MarginEBIT ÷ Revenue | +7.6% | +4.1% | +21.9% | +25.9% | +29.3% |
| Net MarginNet income ÷ Revenue | +5.5% | -2.2% | +18.7% | +20.4% | +27.8% |
| FCF MarginFCF ÷ Revenue | +10.4% | +18.8% | +34.2% | +36.0% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.0% | +15.6% | +13.3% | — | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +18.8% | +164.2% | +52.2% | +16.0% | +18.2% |
Valuation Metrics
JPM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 78% valuation discount to CTCT's 72.8x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs KO's 2.43x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.0B | $51.5B | $135.9B | $896.0B | $355.6B |
| Enterprise ValueMkt cap + debt − cash | $929M | $56.4B | $145.7B | $1.50T | $390.8B |
| Trailing P/EPrice ÷ TTM EPS | 72.75x | -9999.00x | 21.27x | 16.00x | 27.18x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 60.74x | 14.09x | 14.40x | 25.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.74x | 0.90x | 2.43x |
| EV / EBITDAEnterprise value multiple | 21.26x | 53.93x | 11.61x | 18.36x | 26.39x |
| Price / SalesMarket cap ÷ Revenue | 3.08x | 11.71x | 3.27x | 3.20x | 7.42x |
| Price / BookPrice ÷ Book value/share | 3.98x | 7.23x | 2.68x | 2.47x | 10.40x |
| Price / FCFMarket cap ÷ FCF | 30.89x | 66.75x | 9.43x | 8.88x | 67.15x |
Profitability & Efficiency
Evenly matched — CTCT and KO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-1 for MCHP. CTCT carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CTCT scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.1% | -1.4% | +14.9% | +15.9% | +41.1% |
| ROA (TTM)Return on assets | +5.7% | -0.7% | +7.8% | +1.3% | +13.1% |
| ROICReturn on invested capital | +9.0% | +1.8% | +10.1% | +4.5% | +15.8% |
| ROCEReturn on capital employed | +7.9% | +2.1% | +11.9% | +8.9% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 7 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.05x | 0.80x | 0.29x | 2.60x | 1.33x |
| Net DebtTotal debt minus cash | -$92M | $4.9B | $9.8B | $599.0B | $35.2B |
| Cash & Equiv.Liquid assets | $104M | $772M | $7.3B | $343.3B | $10.3B |
| Total DebtShort + long-term debt | $12M | $5.7B | $17.2B | $942.4B | $45.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.78x | 21.32x | 0.74x | 10.70x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $6,905 for CRM. Over the past 12 months, MCHP leads with a +42.9% total return vs CRM's -37.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CRM's -7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | — | +47.9% | -34.2% | -0.5% | +20.3% |
| 1-Year ReturnPast 12 months | — | +42.9% | -37.1% | +21.8% | +17.2% |
| 3-Year ReturnCumulative with dividends | — | +21.4% | -20.4% | +138.2% | +47.0% |
| 5-Year ReturnCumulative with dividends | — | +32.2% | -31.0% | +118.2% | +65.6% |
| 10-Year ReturnCumulative with dividends | — | +310.9% | +108.7% | +465.8% | +121.1% |
| CAGR (3Y)Annualised 3-year return | — | +6.7% | -7.3% | +33.6% | +13.7% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than MCHP's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs CRM's 59.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | — | 1.70x | 0.64x | 0.94x | -0.20x |
| 52-Week HighHighest price in past year | — | $105.91 | $276.80 | $337.25 | $84.04 |
| 52-Week LowLowest price in past year | — | $48.52 | $161.40 | $262.71 | $65.35 |
| % of 52W HighCurrent price vs 52-week peak | — | +89.9% | +59.9% | +95.1% | +98.3% |
| RSI (14)Momentum oscillator 0–100 | 52.6 | 51.4 | 38.9 | 59.1 | 60.6 |
| Avg Volume (50D)Average daily shares traded | — | 10.4M | 12.5M | 7.0M | 12.7M |
Analyst Outlook
KO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MCHP as "Buy", CRM as "Buy", JPM as "Buy", KO as "Buy". Consensus price targets imply 60.2% upside for CRM (target: $266) vs 4.2% for KO (target: $86). For income investors, KO offers the higher dividend yield at 2.46% vs CRM's 1.00%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $107.82 | $265.75 | $339.75 | $86.13 |
| # AnalystsCovering analysts | — | 46 | 97 | 61 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% | +1.0% | +1.9% | +2.5% |
| Dividend StreakConsecutive years of raises | — | 24 | 2 | 15 | 56 |
| Dividend / ShareAnnual DPS | — | $1.82 | $1.66 | $5.95 | $2.04 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +0.2% | +9.3% | +3.9% | +0.2% |
JPM leads in 2 of 6 categories (Valuation Metrics, Total Returns). KO leads in 2 (Risk & Volatility, Analyst Outlook). 2 tied.
CTCT vs MCHP vs CRM vs JPM vs KO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTCT or MCHP or CRM or JPM or KO a better buy right now?
For growth investors, Constant Contact, Inc.
(CTCT) is the stronger pick with 16. 2% revenue growth year-over-year, versus -42. 3% for Microchip Technology Incorporated (MCHP). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Microchip Technology Incorporated (MCHP) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTCT or MCHP or CRM or JPM or KO?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Constant Contact, Inc. at 72. 8x. On forward P/E, Salesforce, Inc. is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CTCT or MCHP or CRM or JPM or KO?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -31. 0% for Salesforce, Inc. (CRM). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CRM's +108. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTCT or MCHP or CRM or JPM or KO?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Microchip Technology Incorporated's 1. 70β — meaning MCHP is approximately -948% more volatile than KO relative to the S&P 500. On balance sheet safety, Constant Contact, Inc. (CTCT) carries a lower debt/equity ratio of 5% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CTCT or MCHP or CRM or JPM or KO?
By revenue growth (latest reported year), Constant Contact, Inc.
(CTCT) is pulling ahead at 16. 2% versus -42. 3% for Microchip Technology Incorporated (MCHP). On earnings-per-share growth, the picture is similar: Constant Contact, Inc. grew EPS 91. 3% year-over-year, compared to -100. 1% for Microchip Technology Incorporated. Over a 3-year CAGR, CTCT leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTCT or MCHP or CRM or JPM or KO?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -0. 0% for Microchip Technology Incorporated — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 6. 0% for CTCT. At the gross margin level — before operating expenses — CRM leads at 77. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTCT or MCHP or CRM or JPM or KO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Salesforce, Inc. (CRM) trades at 14. 1x forward P/E versus 60. 7x for Microchip Technology Incorporated — 46. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRM: 60. 2% to $265. 75.
08Which pays a better dividend — CTCT or MCHP or CRM or JPM or KO?
In this comparison, KO (2.
5% yield), MCHP (1. 9% yield), JPM (1. 9% yield), CRM (1. 0% yield) pay a dividend. CTCT does not pay a meaningful dividend and should not be held primarily for income.
09Is CTCT or MCHP or CRM or JPM or KO better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTCT and MCHP and CRM and JPM and KO?
These companies operate in different sectors (CTCT (Technology) and MCHP (Technology) and CRM (Technology) and JPM (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CTCT is a small-cap high-growth stock; MCHP is a mid-cap quality compounder stock; CRM is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; KO is a large-cap quality compounder stock. MCHP, CRM, JPM, KO pay a dividend while CTCT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.